Abridge has finalized an enterprise-wide agreement with Mayo Clinic to implement the AI-powered clinical documentation platform, starting with approximately 2,000 clinicians who serve over 1 million ...
Advancements in targeted therapies have transformed the treatment landscape for NSCLC, enabling precision medicine approaches that improve outcomes. These therapies focus on specific genetic mutations ...
An two-day inspection of the Midland Regional Hospital Portlaoise by the Health Information and Quality Authority (HIQA), has given the facility a mostly clean bill of health. HIQA’s unannounced ...
LEQEMBI® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI should be initiated in patients with mild ...